5-Fluorouracil/Leucovorin/Oxaliplatin

FOLFOX

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5-Fluorouracil/Leucovorin/Oxaliplatin, covering 2019-04-11 to 2019-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells [Phase 3]

See pricing